Published in Am J Kidney Dis on March 01, 2006
Comparing VA and Non-VA Quality of Care: A Systematic Review. J Gen Intern Med (2016) 1.36
Association of Erythropoietin Dose and Route of Administration with Clinical Outcomes for Patients on Hemodialysis in the United States. Clin J Am Soc Nephrol (2015) 0.79
Measurement invariance of the kidney disease and quality of life instrument (KDQOL-SF) across veterans and non-veterans. Health Qual Life Outcomes (2010) 0.79
Pediatric chronic kidney disease in North Carolina. N C Med J (2008) 0.77
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med (2006) 10.95
Coronary-artery revascularization before elective major vascular surgery. N Engl J Med (2004) 7.80
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50
Watchful waiting vs repair of inguinal hernia in minimally symptomatic men: a randomized clinical trial. JAMA (2006) 6.34
Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36
Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med (2010) 5.27
Amiodarone versus sotalol for atrial fibrillation. N Engl J Med (2005) 5.01
Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med (2015) 3.67
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol (2011) 3.52
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology (2012) 3.46
Fatigue in cancer patients compared with fatigue in the general United States population. Cancer (2002) 3.34
Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med (2007) 3.11
Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA (2011) 2.52
Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer. J Clin Oncol (2002) 2.51
The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum (2008) 2.37
The use of zoledronic acid in men receiving androgen deprivation therapy for prostate cancer with severe osteopenia or osteoporosis. Urology (2010) 2.14
Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol (2006) 2.06
Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? Ann Intern Med (2009) 1.98
Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res (2011) 1.97
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90
Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial. Eur Heart J (2008) 1.87
Gulf War veterans' health: medical evaluation of a U.S. cohort. Ann Intern Med (2005) 1.86
Potential cost savings of erythropoietin administration in end-stage renal disease. Am J Med (2002) 1.83
Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes (2009) 1.83
Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane). Cancer (2003) 1.81
The neurology quality-of-life measurement initiative. Arch Phys Med Rehabil (2011) 1.71
Using focus groups to inform the Neuro-QOL measurement tool: exploring patient-centered, health-related quality of life concepts across neurological conditions. J Neurosci Nurs (2007) 1.70
A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Health Psychol (2002) 1.69
Veterans Health Administration inpatient and outpatient care data: an overview. Eff Clin Pract (2002) 1.64
Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI). Qual Life Res (2009) 1.63
Chronic kidney disease associated with environmental toxins and exposures. Adv Chronic Kidney Dis (2010) 1.60
Chronic multisymptom illness complex in Gulf War I veterans 10 years later. Am J Epidemiol (2005) 1.58
High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes. Kidney Int (2011) 1.56
Change in use of gadolinium-enhanced magnetic resonance studies in kidney disease patients after US Food and Drug Administration warnings: a cross-sectional study of Veterans Affairs Health Care System data from 2005-2008. Am J Kidney Dis (2010) 1.52
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis (2010) 1.51
Perioperative complications after vascular surgery are predicted by the revised cardiac risk index but are not reduced in high-risk subsets with preoperative revascularization. Circ Cardiovasc Qual Outcomes (2009) 1.48
Outcomes of the Veterans Affairs Low Vision Intervention Trial (LOVIT). Arch Ophthalmol (2008) 1.48
Real-time clinical application of quality-of-life assessment in advanced lung cancer. Clin Lung Cancer (2002) 1.47
Preoperative coronary artery revascularization and long-term outcomes following abdominal aortic vascular surgery in patients with abnormal myocardial perfusion scans: a subgroup analysis of the coronary artery revascularization prophylaxis trial. Catheter Cardiovasc Interv (2011) 1.45
Long-term results of a randomized controlled trial of a nonoperative strategy (watchful waiting) for men with minimally symptomatic inguinal hernias. Ann Surg (2013) 1.42
Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial. Clin Trials (2005) 1.31
The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial. J Diabetes Complications (2011) 1.29
The Central American epidemic of CKD. Clin J Am Soc Nephrol (2012) 1.24
Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials. Clin J Am Soc Nephrol (2012) 1.20
Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease. Ann Neurol (2015) 1.20
Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Am J Manag Care (2010) 1.17
Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings. Clin J Am Soc Nephrol (2012) 1.13
Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. Am J Med (2007) 1.09
Cost effectiveness of laparoscopic versus open mesh hernia operation: results of a Department of Veterans Affairs randomized clinical trial. J Am Coll Surg (2006) 1.08
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. Am J Kidney Dis (2009) 1.06
Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. Am J Kidney Dis (2012) 1.05
Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis. Kidney Int (2004) 1.04
Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med (2009) 1.04
Racial differences in markers of mineral metabolism in advanced chronic kidney disease. Clin J Am Soc Nephrol (2012) 1.03
Whether and when to refer patients for predialysis AV fistula creation: complex decision making in the face of uncertainty. Semin Dial (2010) 1.03
Methodology of an ongoing, randomized, controlled trial to improve drug use for elderly patients with chronic heart failure. Am J Geriatr Pharmacother (2004) 1.01
Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial. J Am Pharm Assoc (2003) (2006) 1.00
Item response theory and health-related quality of life in cancer. Expert Rev Pharmacoecon Outcomes Res (2003) 0.99
Factors associated with postoperative complications and hernia recurrence for patients undergoing inguinal hernia repair: a report from the VA Cooperative Hernia Study Group. Am J Surg (2007) 0.99
Changes in kidney function among Nicaraguan sugarcane workers. Int J Occup Environ Health (2015) 0.99
Effect of increased copayments on pharmacy use in the Department of Veterans Affairs. Med Care (2007) 0.97
Tension-free repair versus watchful waiting for men with asymptomatic or minimally symptomatic inguinal hernias: a cost-effectiveness analysis. J Am Coll Surg (2006) 0.96
Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial. Clin Trials (2005) 0.96
Predialysis nephrology care and costs in elderly patients initiating dialysis. Med Care (2011) 0.94
Patient satisfaction and use of Veterans Affairs versus non-Veterans Affairs healthcare services by veterans. Med Care (2005) 0.93
Prevalence of chronic kidney disease in patients with spinal cord injuries/disorders. Am J Nephrol (2012) 0.92
Neuropsychological functioning of U.S. Gulf War veterans 10 years after the war. J Int Neuropsychol Soc (2009) 0.91
Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacists. BMC Public Health (2013) 0.90
Predialysis nephrology care among older veterans using Department of Veterans Affairs or Medicare-covered services. Am J Manag Care (2010) 0.90
Medication acquisition across systems of care and patient-provider communication among older veterans. Am J Health Syst Pharm (2013) 0.90
Distress management. J Natl Compr Canc Netw (2007) 0.89
The Veterans Affairs Low Vision Intervention Trial (LOVIT): design and methodology. Clin Trials (2007) 0.88
Economic evaluation of blind rehabilitation for veterans with macular diseases in the Department of Veterans Affairs. Ophthalmic Epidemiol (2008) 0.88
Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: validation of the Functional Assessment of Cancer Therapy-Neutropenia (FACT-N). Support Care Cancer (2007) 0.88
Using Q-methodology to understand perceived fatigue reported by adolescents with cancer. Psychooncology (2007) 0.88
Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel. Cancer (2002) 0.87
Usefulness of revascularization of patients with multivessel coronary artery disease before elective vascular surgery for abdominal aortic and peripheral occlusive disease. Am J Cardiol (2008) 0.86
Anorexia/cachexia-related quality of life for children with cancer. Cancer (2005) 0.85
Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T). Am Heart J (2007) 0.85
Parkinson's disease medication use and costs following deep brain stimulation. Mov Disord (2012) 0.84
Validation of erythropoietin use data on Medicare's End-Stage Renal Disease Medical Evidence Report. J Rehabil Res Dev (2010) 0.84
Response to six classes of antihypertensive medications by body mass index in a randomized controlled trial. J Clin Hypertens (Greenwich) (2003) 0.84
Comparing VA and private sector healthcare costs for end-stage renal disease. Med Care (2012) 0.83
Comparison of health-related quality of life measures for chronic renal failure: quality of well-being scale, short-form-6D, and the kidney disease quality of life instrument. Qual Life Res (2008) 0.83
Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery. Ann Thorac Surg (2006) 0.83
Mental health of US Gulf War veterans 10 years after the war. Br J Psychiatry (2007) 0.83